Rising Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RISING, and what generic and branded alternatives to RISING drugs are available?
RISING has two hundred and fifty-nine approved drugs.
There are three tentative approvals on RISING drugs.
Drugs and US Patents for Rising
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 090110-001 | Jun 29, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Rising | TADALAFIL | tadalafil | TABLET;ORAL | 206956-003 | Apr 29, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Rising | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, CHEWABLE;ORAL | 205756-002 | Nov 7, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Rising
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | 3,497,599 | ⤷ Try a Trial |
Rising | ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353-001 | Dec 29, 1986 | 4,167,574 | ⤷ Try a Trial |
Rising | SUFENTA PRESERVATIVE FREE | sufentanil citrate | INJECTABLE;INJECTION | 019050-001 | May 4, 1984 | 3,998,834 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.